MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $297 | +20.2% | 6,813 | -0.3% | 0.00% | +50.0% |
Q2 2023 | $247 | -6.8% | 6,831 | -4.2% | 0.00% | 0.0% |
Q1 2023 | $265 | -28.8% | 7,132 | -13.0% | 0.00% | -33.3% |
Q4 2022 | $372 | -99.9% | 8,201 | +4.7% | 0.00% | -40.0% |
Q3 2022 | $547,000 | +5.0% | 7,832 | +1.0% | 0.01% | 0.0% |
Q2 2022 | $521,000 | -31.8% | 7,754 | -16.6% | 0.01% | -16.7% |
Q1 2022 | $764,000 | -69.5% | 9,292 | -45.7% | 0.01% | -33.3% |
Q4 2021 | $2,508,000 | +99.4% | 17,100 | +140.5% | 0.01% | -18.2% |
Q3 2021 | $1,258,000 | +3.4% | 7,111 | -5.6% | 0.01% | +10.0% |
Q2 2021 | $1,217,000 | +16.7% | 7,533 | +23.7% | 0.01% | -74.4% |
Q1 2021 | $1,043,000 | -28.9% | 6,091 | -8.8% | 0.04% | -30.4% |
Q4 2020 | $1,467,000 | +51.4% | 6,678 | +14.4% | 0.06% | +33.3% |
Q3 2020 | $969,000 | +44.2% | 5,835 | -0.8% | 0.04% | +35.5% |
Q2 2020 | $672,000 | +71.4% | 5,883 | +15.3% | 0.03% | +210.0% |
Q1 2020 | $392,000 | -37.9% | 5,101 | +4.2% | 0.01% | -16.7% |
Q4 2019 | $631,000 | +82.9% | 4,895 | +10.7% | 0.01% | +71.4% |
Q3 2019 | $345,000 | -25.3% | 4,422 | -1.3% | 0.01% | -36.4% |
Q2 2019 | $462,000 | +94.9% | 4,482 | +38.5% | 0.01% | +83.3% |
Q1 2019 | $237,000 | – | 3,237 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |